Spots Global Cancer Trial Database for colorectal tumors
Every month we try and update this database with for colorectal tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation | NCT05358249 | KRAS G12C Mutan... Carcinoma, Non-... Carcinoma, Non-... Non-Small Cell ... Non-Small Cell ... Nonsmall Cell L... Colorectal Canc... Colorectal Carc... Colorectal Neop... Colorectal Tumo... Neoplasms, Colo... | JDQ443 trametinib Ribociclib cetuximab | 18 Years - | Novartis | |
| A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer | NCT00478634 | Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | RAD001, Cetuxim... | 18 Years - 65 Years | Novartis | |
| Targeted Forceps Biopsy for Colorectal Tumors | NCT03604237 | Colorectal Neop... | Targeted group | 19 Years - 85 Years | Kyungpook National University Hospital | |
| Nelfinavir, a Phase I/Phase II Rectal Cancer Study | NCT00704600 | Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | nelfinavir | 18 Years - | Maastricht Radiation Oncology | |
| Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC) | NCT01909362 | Colorectal Neop... Advanced Metast... | 18 Years - | US Oncology Research | ||
| ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer | NCT01675128 | Colorectal Neop... Colorectal Carc... Colorectal Tumo... | ISIS 183750 Irinotecan | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread | NCT03377361 | Colorectal Canc... Colorectal Tumo... Colorectal Carc... Colorectal Neop... | Nivolumab Trametinib Ipilimumab Regorafenib | 18 Years - | Bristol-Myers Squibb | |
| A Pilot Study to Determine Fructose Uptake by Primary Human Colorectal Tumors | NCT05136092 | Colorectal Tumo... | Cohort 1: HFCS ... Cohort 2: D-Xyl... | 18 Years - | Weill Medical College of Cornell University | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Predictive Factors for Anastomotic Leakage After Colorectal Surgery | NCT02347735 | Anastomotic Lea... Colorectal Canc... Anastomotic Lea... Colorectal Neop... Colorectal Carc... Colorectal Tumo... | No intervention... | 18 Years - | Maastricht University Medical Center | |
| Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation | NCT05358249 | KRAS G12C Mutan... Carcinoma, Non-... Carcinoma, Non-... Non-Small Cell ... Non-Small Cell ... Nonsmall Cell L... Colorectal Canc... Colorectal Carc... Colorectal Neop... Colorectal Tumo... Neoplasms, Colo... | JDQ443 trametinib Ribociclib cetuximab | 18 Years - | Novartis | |
| Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI) | NCT01671592 | Colorectal Neop... Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | DC Vaccine | 18 Years - | University of Pittsburgh | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population | NCT01793207 | Colorectal Neop... Adenoma Colorectal Tumo... | 18 Years - 85 Years | Cairo University | ||
| Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer | NCT02244632 | Colorectal Neop... | Modufolin (arfo... Fluorouracil Oxaliplatin Irinotecan Bevacizumab | 18 Years - | Isofol Medical AB | |
| Predictive Factors for Anastomotic Leakage After Colorectal Surgery | NCT02347735 | Anastomotic Lea... Colorectal Canc... Anastomotic Lea... Colorectal Neop... Colorectal Carc... Colorectal Tumo... | No intervention... | 18 Years - | Maastricht University Medical Center | |
| A Pilot Study to Determine Fructose Uptake by Primary Human Colorectal Tumors | NCT05136092 | Colorectal Tumo... | Cohort 1: HFCS ... Cohort 2: D-Xyl... | 18 Years - | Weill Medical College of Cornell University | |
| Targeted Forceps Biopsy for Colorectal Tumors | NCT03604237 | Colorectal Neop... | Targeted group | 19 Years - 85 Years | Kyungpook National University Hospital | |
| Effect of Peritoneal Lavage With Clindamycin-Gentamicin Solution & Oncologic Outcome | NCT02399059 | Colorectal Tumo... | Antibiotic lava... Normal saline l... | - | Hospital General Universitario Elche | |
| Study Evaluating MAC-321 in Colorectal Cancer | NCT00063427 | Colorectal Neop... Colonic Neoplas... Rectal Neoplasm... | MAC-321 | 18 Years - | Wyeth is now a wholly owned subsidiary of Pfizer | |
| VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC) | NCT04166383 | Metastatic Colo... Colorectal Neop... Colorectal Carc... Colorectal Canc... Colorectal Tumo... | Vascular Biogen... Nivolumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Dendritic Cell Vaccination for Patients With Solid Tumors | NCT01291420 | Glioblastoma Renal Cell Carc... Sarcomas Breast Cancers Malignant Mesot... Colorectal Tumo... | autologous dend... | 18 Years - | University Hospital, Antwerp | |
| ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer | NCT01675128 | Colorectal Neop... Colorectal Carc... Colorectal Tumo... | ISIS 183750 Irinotecan | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI) | NCT01671592 | Colorectal Neop... Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | DC Vaccine | 18 Years - | University of Pittsburgh | |
| Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer | NCT00558051 | Metastatic Colo... | DC-based vaccin... DC-based vaccin... DC-based vaccin... | 18 Years - 80 Years | University of Pittsburgh | |
| Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers | NCT00503035 | Familial Adenom... | Celecoxib Colonoscopy Bio... | 16 Years - | M.D. Anderson Cancer Center | |
| An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread | NCT03377361 | Colorectal Canc... Colorectal Tumo... Colorectal Carc... Colorectal Neop... | Nivolumab Trametinib Ipilimumab Regorafenib | 18 Years - | Bristol-Myers Squibb | |
| Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver | NCT00149396 | Colorectal Canc... Liver Neoplasms | NV1020 | 18 Years - | MediGene | |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin | NCT01157039 | Colorectal Carc... Neoplasms, Colo... Colorectal Canc... Colorectal Tumo... Metastasis | Glutamine | 18 Years - | AHS Cancer Control Alberta | |
| Study Evaluating EKB-569 in Advanced Colorectal Cancer | NCT00072748 | Colorectal Neop... Colonic Neoplas... Rectal Neoplasm... | EKB-569 | 18 Years - | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver | NCT00149396 | Colorectal Canc... Liver Neoplasms | NV1020 | 18 Years - | MediGene |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
